Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/28/24 15:50 | 3/28/24 | EYEN | Health | Drug | Pharmaceutical Preparations | Grant Stuart M. | DE | T | 6 | P.m | 585 | 1.69 | 0 | 346 | 7 | 5,431 | D | |||||||||||||||
12/5/23 16:54 | 12/30/22 | EYEN | Health | Drug | Pharmaceutical Preparations | Rowe Michael M | NY | DO | CEO | 3 | P.m | 26 | 1.51 | 0 | 17 | 112 | 33 | D | ||||||||||||||
10/2/23 10:04 | 9/29/23 | EYEN | Health | Drug | Pharmaceutical Preparations | Strahlman Ellen R | NY | D | 2 | P | 39 | 2.64 | 0 | 15 | 25 | 75 | D | |||||||||||||||
5/31/23 18:31 | 5/31/23 | EYEN | Health | Drug | Pharmaceutical Preparations | Gandolfo John P | NY | O | CFO | 1 | P | 6 | 2.79 | 0 | 2 | 33 | 8 | D | ||||||||||||||
5/31/23 10:48 | 5/26/23 | EYEN | Health | Drug | Pharmaceutical Preparations | Kern Bren | NY | O | COO | 1 | P | 7 | 2.73 | 0 | 3 | 3 | D | |||||||||||||||
5/30/23 10:13 | 5/26/23 | EYEN | Health | Drug | Pharmaceutical Preparations | Mather Charles E IV | NY | D | 3 | P | 35 | 3.14 | 0 | 11 | 17 | 78 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |